http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108250219-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-473 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2017-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108250219-B |
| titleOfInvention | A kind of drug and preparation method thereof for treating thyroiditis |
| abstract | The present invention relates to one kind to have medicative compound, its stereoisomer, prodrug or pharmaceutically acceptable salt, its pharmaceutical composition, preparation method and application for thyroiditis.Test result shows, the case where Hashimoto thyroiditis mouse weight that the compounds of this invention can improve high iodine water induction is decreased obviously and TPOAb and TGAb is substantially increased, it is shown that the compounds of this invention is for the good therapeutic effect of thyroiditis especially Hashimoto thyroiditis；Compared with positive control dexamethasone, the therapeutic effect of the compounds of this invention is even more significant.Therefore, the compounds of this invention is suitable as the drug for the treatment of thyroiditis especially Hashimoto thyroiditis. |
| priorityDate | 2017-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 109.